Cleared Traditional

K931189 - P.F.C. TOTAL HIP SYSTEM POROUS COATED MODULAR ACET

K931189 is an FDA 510(k) clearance for P.F.C. TOTAL HIP SYSTEM POROUS COATED M..., manufactured by Johnson & Johnson Orthopaedics, Inc.. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 337-day FDA review.

K931189 · Johnson & Johnson Orthopaedics, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1994
Decision
337d
Days
Class 2
Risk

K931189 is an FDA 510(k) clearance for the P.F.C. TOTAL HIP SYSTEM POROUS COATED MODULAR ACET. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Johnson & Johnson Orthopaedics, Inc. (Raynham, US). The FDA issued a Cleared decision on February 9, 1994 after a review of 337 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Johnson & Johnson Orthopaedics, Inc. devices

FDA 510(k) Submission Details - K931189

510(k) Number K931189 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 09, 1993
Decision Date February 09, 1994
Days to Decision 337 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
215d slower than avg
Panel avg: 122d · This submission: 337d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 476
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K931189.
MALLORY-HEAD TOTAL HIP SYSTEM
K921181 · Biomet, Inc. · Feb 1994
BIMETRIC TOTAL HIP SYSTEM
K921224 · Biomet, Inc. · Feb 1994
INTEGRAL TOTAL HIP SYSTEM
K921225 · Biomet, Inc. · Feb 1994
BIOPRO ZIRALLOY MODULAR FEMORAL HEADS, MODIFIED
K925682 · Biopro, Inc. · Jan 1994
SL-PLUS & SLR-PLUS STEMS W/BIOLOX CERAMIC HEADS
K930963 · Encore Orthopedics, Inc. · Jan 1994
P.F.C. TOTAL HIP SYSTEM POROUS COATED MODULAR
K930712 · Johnson & Johnson Orthopaedics, Inc. · Oct 1993